Theravance Selected Fundamentals

    The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

    Cash and Equivalents Analysis

    Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
    Theravance 
    Cash 
     = 
    Bank Deposits 
    +  
    Liquidities 
     = 
    206.19 M

    About Cash and Equivalents

    Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually 3 months).Compare to competition
    In accordance with recently published financial statements Theravance Inc has 206.19 M in Cash and Equivalents. This is much higher than that of the sector, and significantly higher than that of Cash and Equivalents industry, The Cash and Equivalents for all stocks is over 1000% lower than the firm.

    Theravance Inc Fundamental Drivers Relationships

    Theravance Inc is rated below average in current liabilities category among related companies. It is rated below average in earnings per share category among related companies .

    Peer Comparison

    Theravance Earnings Per Share Comparison
    Theravance is currently under evaluation in earnings per share category among related companies.

    Did you try this?

    Run Pair Correlation Now
       

    Pair Correlation

    Compare performance and examine historical correlation between any two equity instruments
    Hide  View All  NextLaunch Pair Correlation